Emerging Growth Research Announces New Flash Report on First Phosphate Corp.
Emerging Growth Research sees a possible path to less equity financing, but the cited support and letters are not committed facilities.
Rhea-AI Summary
Emerging Growth Research released a company-sponsored report on First Phosphate (PHOS), highlighting potential project-financing support of up to US$212.5 million. Swiss Export Risk Insurance support could cover eligible Swiss equipment for the Bégin-Lamarche mine in Quebec and goods and services for its processing facility.
Other potential funding sources include a Danish fund’s letter of intent for a guarantee of up to C$275 million, a US export bank’s letter of interest for up to US$170 million, and letters of intent from Italian institutions for a proposed phosphoric acid plant. The report also identifies C$21.5 million in Government of Canada contributions. The Bégin-Lamarche preliminary economic assessment estimates mine capital expenditures of approximately C$675 million. Emerging Growth Research believes these funding options could reduce the need to issue equity, but the support and letters have not become committed financing facilities. A feasibility study is expected in early 2027.
Positive
- Swiss Export Risk Insurance support offers potential financing of up to US$212.5 million for eligible project costs.
- Danish fund letter of intent covers a potential guarantee of up to C$275 million.
- US export bank letter of interest covers up to US$170 million.
- Italian institutions’ letters of intent concern the proposed Port Saguenay phosphoric acid plant.
- Government of Canada contributions total C$21.5 million among the identified funding sources.
Negative
- Potential financing support and letters still need to become committed facilities.
- Mine capital expenditures are estimated at approximately C$675 million in the preliminary economic assessment.
- Feasibility study is expected in early 2027 and has not been completed.
- Company-sponsored research cost First Phosphate US$1,500; Emerging Growth Research disclosed a conflict of interest.
Key Figures
- SERV potential financing support
- Up to US$212.5 million
- Bégin-Lamarche project capital cost
- EIFO guarantee
- Up to C$275 million
- Letter of intent
- Export-Import Bank of the United States letter of interest
- Up to US$170 million
- Potential project financing source
- Government of Canada contributions
- C$21.5 million
- Project financing sources
- Feasibility study timing
- Early 2027
- Expected project milestone
- Research report compensation
- US$1,500 paid; US$0 expected over the following 12 months
- Company-sponsored Flash Report
Historical Context
-
SERV provided support for potential buyer-credit financing tied to eligible Swiss exports.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
lithium iron phosphate technical
export credit agency financial
non-dilutive financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK CITY, NY / ACCESS Newswire / September 28, 2026 / Emerging Growth Research ("Emerging Growth Research" or "EGR") today announced the release of its company-sponsored research Flash Report on First Phosphate Corp. (NASDAQ:PHOS)(CSE:PHOS)(OTCQX:FRSPF), a mineral development and clean technology company building a vertically integrated North American supply chain for lithium iron phosphate ("LFP") battery materials.
The Flash Report provides an update on the Company's recent financing developments related to its Bégin-Lamarche igneous phosphate project in Quebec. The report focuses on support from Swiss Export Risk Insurance ("SERV") and the potential implications for project financing and future shareholder dilution.
Key Highlights
SERV Provides Potential Financing Support -- First Phosphate has secured support from Swiss Export Risk Insurance for up to US
Additional Export Credit Agency Support -- SERV's support adds another potential source of export credit agency-backed financing to a growing group of G7-aligned funding sources supporting First Phosphate's development plans.
Growing Project Financing Stack -- First Phosphate's potential financing sources include a letter of intent from Denmark's state-backed Export and Investment Fund (EIFO) for a guarantee of up to C
Potential Reduction in Equity Financing Requirements -- EGR believes the expanding export credit agency-backed financing stack could provide First Phosphate with additional options for funding project capital expenditures through debt and other non-dilutive sources rather than equity issuance. The report notes that the Bégin-Lamarche PEA estimates mine capital expenditures of approximately C
Feasibility Study Remains a Key Catalyst -- EGR views the conversion of the current letters of intent and support into committed financing facilities, together with the Company's feasibility study expected in early 2027, as important developments for the project and its financing structure.
The full Flash Report from Emerging Growth Research is available at:
https://app.accessnewswire.com/admin/release/attachment/89493
Or
https://emerginggrowth.com/profile/frspf/ (on the right side of the page as you scroll down)
About First Phosphate Corp.
First Phosphate Corp. (Nasdaq:PHOS)(CSE:PHOS)(OTCQX:FRSPF)(FSE:KD0) is a mineral exploration and development and clean technology company dedicated to building and reshoring a vertically integrated mine-to-market supply chain for the production of LFP batteries in North America. Target markets include energy storage, data centers, robotics, mobility, and national security. First Phosphate's flagship Begin-Lamarche property, located in Saguenay-Lac-Saint-Jean, Quebec, Canada, represents a rare North American igneous phosphate resource producing high-purity phosphate characterized by very low levels of impurities. For more information, please visit www.FirstPhosphate.com.
About Emerging Growth Research
Emerging Growth Research, LLC ("EGR") is a research firm focused on emerging growth companies, including small-, micro- and nano-cap companies across healthcare, biotechnology, energy, metals and mining, technology and other emerging industries. EGR provides research reports, quarterly updates, flash reports and other investor-focused content covering emerging growth companies.
Emerging Growth Research also provides company-sponsored research services. The research referenced in this press release is company-sponsored research.
Contact:
Emerging Growth Research
Research@EmergingGrowth.com
www.EmergingGrowth.com
Forward-Looking Statements
This press release contains forward-looking statements concerning business operations, financial performance, project development, financing and permitting timelines, capital markets opportunities, and future growth expectations. These statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied. Important risk factors include, but are not limited to, permitting and regulatory timing, the availability and terms of project financing, commodity price assumptions, execution risk associated with feasibility and development activities, and the Company's ability to successfully execute its growth strategy.
Disclosure
This report was prepared for institutional and professional investors ONLY, and it is also known as Company Sponsored Research ("CSR"). Collectively, however ("EGR Report(s)").
Be advised that this EGR Report is being provided by Emerging Growth Research LLC ("EGR") solely for informational purposes, is not the opinion of EmergingGrowth.com ("EG"), should not be construed as an offer or solicitation to buy or sell securities, and should not be considered in any decision to buy or sell any security mentioned within the EGR Reports. All information contained in the EGR Report as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive, timely, or correct. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. Because EGR is compensated as detailed herein and EG receives Licensing fees from EGR, as also detailed herein, EG and EGR have a conflict of interest and strongly urge you to consult your own independent financial, investment, tax, and legal advisors prior to purchasing or selling any securities mentioned herein.
The analyst that has prepared and is responsible for the content of this report has stated that neither he/she, nor any of his/her associates both professional and personal, to the best of his/her knowledge have no personal or professional relationship with any of the companies or principals of any companies mentioned within, other than providing services that EGR may offer.
EGR is being compensated by the subject Company of this report. EGR was paid one thousand five hundred USD for this report and expects to receive an additional zero dollars over the following 12 months. EGR may have also received additional past compensation, EGR may receive future compensation, and EG may receive compensation for additional services such as presenting on the Emerging Growth Conference or investor or public relations services, details about which can be found in the full disclosure, here: https://emerginggrowth.com/frspf-phos-egr-report-disclosure/.
It is the intent of EGR to provide continuing coverage on a quarterly basis, or otherwise for the subject Company of this report; however, EGR and EG will not notify readers of this report if coverage by EGR, for any reason is terminated.
The reader or user of this content agrees that neither EGR and / or EG nor the analysts, directors, officers, employees, representatives, independent contractors, agents or affiliates of EGR and EG shall be liable or held liable for any omissions, errors, or inaccuracies, regardless of cause, foreseeability, or the lack of timeliness of this or any of our other reports to users. This lack of liability extends to direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, losses, lost income, lost profit, or opportunity costs.
Again, all information contained herein should be independently verified by your own research and your own independent financial, investment, tax, and legal advisors prior to purchasing or selling any securities mentioned herein.
In addition to the specific disclosures mentioned herein, you are encouraged to read our general disclosure here: EmergingGrowth.com/Disclosure.
Rating Definitions
Buy,
Buy-Extended, near-term EPS and/or revenue horizon is challenging with strong long-term appreciation possibility.
Buy-Emerging, initial stages with low revenue and the potential for large returns with higher risk and volatility.
Hold, perform similar to market.
Sell,
© Copyright 2026 Emerging Growth Research LLC
No part of this material may be copied, photocopied, or duplicated in any form by any means or redistributed without the prior written consent of Emerging Growth Research LLC.
SOURCE: First Phosphate Corp.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much Swiss export insurance support is available for First Phosphate’s Bégin-Lamarche project?
Swiss Export Risk Insurance support provides potential financing of up to US$212.5 million, not a committed facility. It would cover eligible Swiss machinery and equipment for the mine, along with goods and services for the associated processing facility.
How much was Emerging Growth Research paid for its First Phosphate report?
Emerging Growth Research was paid US$1,500 by First Phosphate for the company-sponsored report. It expects an additional zero dollars over the following 12 months and disclosed a conflict of interest involving its compensation and licensing fees.